Decreased C-Src Expression Enhances Osteoblast Differentiation and Bone Formation

c-src deletion in mice leads to osteopetrosis as a result of reduced bone resorption due to an alteration of the osteoclast. We report that deletion/reduction of Src expression enhances osteoblast differentiation and bone formation, contributing to the increase in bone mass. Bone histomorphometry showed that bone formation was increased in Src null compared with wild-type mice. In vitro, alkaline phosphatase (ALP) activity and nodule mineralization were increased in primary calvarial cells and in SV40-immortalized osteoblasts from Src−/− relative to Src+/+ mice. Src-antisense oligodeoxynucleotides (AS-src) reduced Src levels by ∼60% and caused a similar increase in ALP activity and nodule mineralization in primary osteoblasts in vitro. Reduction in cell proliferation was observed in primary and immortalized Src−/− osteoblasts and in normal osteoblasts incubated with the AS-src. Semiquantitative reverse transcriptase-PCR revealed upregulation of ALP, Osf2/Cbfa1 transcription factor, PTH/PTHrP receptor, osteocalcin, and pro-alpha 2(I) collagen in Src-deficient osteoblasts. The expression of the bone matrix protein osteopontin remained unchanged. Based on these results, we conclude that the reduction of Src expression not only inhibits bone resorption, but also stimulates osteoblast differentiation and bone formation, suggesting that the osteogenic cells may contribute to the development of the osteopetrotic phenotype in Src-deficient mice.

[1]  J. Brugge,et al.  Blood platelets express high levels of the pp60c-src-specific tyrosine kinase activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[2]  A. Parfitt Bone histomorphometry: standardization of nomenclature, symbols and units (summary of proposed system). , 1988, Bone.

[3]  G. Rodan,et al.  Integrin-mediated signaling in the regulation of osteoclast adhesion and activation. , 1998, Frontiers in bioscience : a journal and virtual library.

[4]  H. Ihn,et al.  Sp3 is a transcriptional activator of the human α2(I) collagen gene , 1997 .

[5]  T. Hunter,et al.  Protein-tyrosine kinases. , 1985, Annual review of biochemistry.

[6]  H. Ihn,et al.  Sp3 is a transcriptional activator of the human alpha2(I) collagen gene. , 1997, Nucleic acids research.

[7]  G. Schettini,et al.  Antisense oligonucleotides as therapeutic agents. , 1997, Pharmacological research.

[8]  M. Young,et al.  Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. , 1995, Acta orthopaedica Scandinavica. Supplementum.

[9]  D. Lt,et al.  Integrin-mediated Signaling in the Regulation of Osteoclast Adhesion and Activation , 1998 .

[10]  C. Stein Controversies in the cellular pharmacology of oligodeoxynucleotides. , 1997, Antisense & nucleic acid drug development.

[11]  R. Baron,et al.  Osteoclasts express high levels of pp60c-src in association with intracellular membranes , 1992, The Journal of cell biology.

[12]  Sheila M. Thomas,et al.  Cellular functions regulated by Src family kinases. , 1997, Annual review of cell and developmental biology.

[13]  M. McKee,et al.  Cells in vivo and in vitro from osteopetrotic mice homozygous for c-src disruption show suppression of synthesis of osteopontin, a multifunctional extracellular matrix protein. , 1996, Oncogene.

[14]  E. Jimi,et al.  Regulation of Osteoclast Function , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  C. Bennett,et al.  Antisense oligonucleotides: is the glass half full or half empty? , 1998, Biochemical pharmacology.

[16]  R. Castelein The Netherlands Orthopedic Society Utrecht, October 8, 1994 , 1995 .

[17]  G. Stein,et al.  Proliferation and differentiation of osteoblasts in osteopetrotic rats: modification in expression of genes encoding cell growth and extracellular matrix proteins. , 1989, Connective tissue research.

[18]  M. Resh,et al.  Myristylation and palmitylation of Src family members: The fats of the matter , 1994, Cell.

[19]  G. Karsenty,et al.  A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. , 1999, Genes & development.

[20]  R. Baron,et al.  Progressive increase in bone mass and development of odontomas in aging osteopetrotic c-src-deficient mice. , 2000, Bone.

[21]  G. Rodan,et al.  Stimulation of Mouse Osteopontin Promoter by v-Src Is Mediated by a CCAAT Box-binding Factor* , 1996, The Journal of Biological Chemistry.

[22]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[23]  T. Yoneda,et al.  Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice. , 1992, The Journal of clinical investigation.

[24]  Michael J. Eck,et al.  Three-dimensional structure of the tyrosine kinase c-Src , 1997, Nature.

[25]  P. Robey,et al.  Human bone cells in vitro. , 1985, Calcified tissue international.

[26]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[27]  Philippe Soriano,et al.  Promoter interactions in retrovirus vectors introduced into fibroblasts and embryonic stem cells , 1991, Journal of virology.

[28]  G. Stein,et al.  Abnormalities of phosphoprotein gene expression in three osteopetrotic rat mutations: Elevated mrna transcripts, protein synthesis, and accumulation in bone of mutant animals , 1994, Journal of cellular physiology.

[29]  M. Drezner,et al.  Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  G. Karsenty,et al.  Functional Hierarchy between Two OSE2 Elements in the Control of Osteocalcin Gene Expression in Vivo * , 1998, The Journal of Biological Chemistry.

[31]  J. Bonjour,et al.  Sequence and activity of parathyroid hormone/parathyroid hormone-related protein receptor promoter region in human osteoblast-like cells. , 1998, Gene.

[32]  Y. Ito,et al.  Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. , 1998, Bone.

[33]  Sakae Tanaka,et al.  c-Cbl is downstream of c-Src in a signalling pathway necessary for bone resorption , 1996, Nature.

[34]  P. Kelly,et al.  QUANTITATIVE MICRORADIOGRAPHIC STUDIES OF NORMAL AND OSTEOPOROTIC BONE. , 1965, The Journal of bone and joint surgery. American volume.

[35]  T. Yoneda,et al.  Osteopetrosis in Src-deficient mice is due to an autonomous defect of osteoclasts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[36]  J. Parsons,et al.  Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. , 1997, Current opinion in cell biology.

[37]  P. Härkönen,et al.  Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. , 1998, Bone.

[38]  R. Wagner The state of the art in antisense research , 1995, Nature Genetics.

[39]  W. Wetsel,et al.  Protein Kinase C Modulates Estrogen Receptors in Differentiated Osteoblastic Cells In Vitro , 1998, Steroids.

[40]  Allan Bradley,et al.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice , 1991, Cell.

[41]  H. Harris,et al.  Structure of the human liver/bone/kidney alkaline phosphatase gene. , 1988, The Journal of biological chemistry.

[42]  J. Bolen,et al.  Identification of a novel neuronal C-SRC exon expressed in human brain , 1990, Molecular and cellular biology.